IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $204,000 | -23.0% | 3,455 | -20.2% | 0.01% | -11.1% |
| Q4 2019 | $265,000 | +5.2% | 4,332 | +0.9% | 0.01% | 0.0% |
| Q3 2019 | $252,000 | -12.2% | 4,294 | -3.7% | 0.01% | -10.0% |
| Q2 2019 | $287,000 | -17.3% | 4,460 | +2.2% | 0.01% | -16.7% |
| Q1 2019 | $347,000 | +23.0% | 4,365 | -16.7% | 0.01% | +9.1% |
| Q4 2018 | $282,000 | +0.4% | 5,239 | -3.2% | 0.01% | +10.0% |
| Q3 2018 | $281,000 | +20.6% | 5,412 | -3.0% | 0.01% | +11.1% |
| Q2 2018 | $233,000 | +2.2% | 5,579 | +5.9% | 0.01% | 0.0% |
| Q1 2018 | $228,000 | -7.3% | 5,268 | +9.0% | 0.01% | -10.0% |
| Q4 2017 | $246,000 | -5.0% | 4,835 | -5.9% | 0.01% | -9.1% |
| Q3 2017 | $259,000 | -7.2% | 5,136 | -6.0% | 0.01% | -8.3% |
| Q2 2017 | $279,000 | +39.5% | 5,463 | +9.9% | 0.01% | +20.0% |
| Q1 2017 | $200,000 | -16.3% | 4,969 | -0.6% | 0.01% | -16.7% |
| Q4 2016 | $239,000 | – | 4,997 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |